News | November 15, 2023
JB Pharma Q2 FY24 PAT up 36% to Rs. 151 Cr
Reports revenue growth of 9% to INR 882 crores in Q2 FY24
Reports revenue growth of 9% to INR 882 crores in Q2 FY24
Likmez oral suspension is the first and only FDA-approved liquid option for patients with adherence hurdles such as dysphagia, difficulty swallowing
Yesafili, received marketing authorization approval from the European Commission for the European Union
This collaboration underscores WOTR's unwavering commitment to strengthening rural communities against the unpredictable variations of climate change
We are redesigning Bayer to focus only on what’s essential for our mission, ‘Health for all, hunger for none’”
The agreement demonstrates a shared commitment to advance precision medicine and improve patient outcomes in the region
Aster Whitefield will be Aster's 3 rd multi-specialty hospital in Bengaluru and overall 19th hospital in India
The drug will be marketed by Sun Pharma under the brand name RYTSTAT
Additional premium services in RegXcellence will include access to BASF’s Product Carbon Footprint data and direct downloads of audit reports
Three block copolymers added to RESOMER portfolio of bioabsorbable polymers
Subscribe To Our Newsletter & Stay Updated
